NasdaqGM - Nasdaq Real Time Price USD

RAPT Therapeutics, Inc. (RAPT)

Compare
1.6700 +0.0400 (+2.45%)
At close: January 3 at 4:00:01 PM EST
1.6900 +0.02 (+1.20%)
After hours: January 3 at 7:55:41 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
1,527.0000
3,813.0000
5,042.0000
Operating Expense
114,853.0000
127,062.0000
87,322.0000
73,022.0000
58,256.0000
Operating Income
-114,853.0000
-127,062.0000
-85,795.0000
-69,209.0000
-53,214.0000
Other Income Expense
7,361.0000
10,264.0000
1,957.0000
5.0000
1,312.0000
Pretax Income
-107,492.0000
-116,798.0000
-83,838.0000
-69,204.0000
-51,902.0000
Tax Provision
--
--
--
--
990.0000
Net Income Common Stockholders
-107,492.0000
-116,798.0000
-83,838.0000
-69,204.0000
-52,892.0000
Diluted NI Available to Com Stockholders
-107,492.0000
-116,798.0000
-83,838.0000
-69,204.0000
-52,892.0000
Basic EPS
-2.78
-3.05
-2.58
-2.53
-2.19
Diluted EPS
-2.78
-3.05
-2.58
-2.53
-2.19
Basic Average Shares
38,696.4770
38,338.1610
32,540.4060
27,390.3260
24,134.3050
Diluted Average Shares
38,696.4770
38,338.1610
32,540.4060
27,390.3260
24,134.3050
Total Operating Income as Reported
-114,853.0000
-127,062.0000
-85,795.0000
-69,209.0000
-53,214.0000
Total Expenses
114,853.0000
127,062.0000
87,322.0000
73,022.0000
58,256.0000
Net Income from Continuing & Discontinued Operation
-107,492.0000
-116,798.0000
-83,838.0000
-69,204.0000
-52,892.0000
Normalized Income
-107,492.0000
-116,798.0000
-83,838.0000
-69,204.0000
-52,892.0000
EBIT
-114,853.0000
-127,062.0000
-85,795.0000
-69,209.0000
-53,214.0000
EBITDA
-113,614.0000
-125,846.0000
-84,748.0000
-68,213.0000
-52,091.0000
Reconciled Depreciation
1,239.0000
1,216.0000
1,047.0000
996.0000
1,123.0000
Net Income from Continuing Operation Net Minority Interest
-107,492.0000
-116,798.0000
-83,838.0000
-69,204.0000
-52,892.0000
Normalized EBITDA
-113,614.0000
-125,846.0000
-84,748.0000
-68,213.0000
-52,091.0000
Tax Rate for Calcs
--
--
--
--
0.0003
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TRAW Traws Pharma, Inc.
8.66
-0.12%
 
COEP Coeptis Therapeutics Holdings, Inc.
5.72
-3.21%
 
SPRC SciSparc Ltd.
0.5279
+34.46%
 
PBM Psyence Biomedical Ltd.
2.0200
-2.88%
 
NLSP NLS Pharmaceutics AG
2.1600
-0.92%
 
TOVX Theriva Biologics, Inc.
1.5900
-3.64%
 
APTO Aptose Biosciences Inc.
0.2361
+0.25%
 
VINC Vincerx Pharma, Inc.
0.2305
-2.04%
 
PLRZ Polyrizon Ltd.
1.9400
+6.01%
 
REVB Revelation Biosciences, Inc.
0.6470
-1.52%